BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9766444)

  • 1. p53-dependent and -independent differentiation of leukemic U-937 cells: relationship to cell cycle control.
    Ehinger M; Bergh G; Johnsson E; Baldetorp B; Olsson I; Gullberg U
    Exp Hematol; 1998 Oct; 26(11):1043-52. PubMed ID: 9766444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein.
    Ehinger M; Bergh G; Johnsson E; Gullberg U; Olsson I
    Cell Growth Differ; 1997 Oct; 8(10):1127-37. PubMed ID: 9342191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K; Ehinger M; Svedberg H; Gullberg U
    Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
    Ehinger M; Nilsson E; Persson AM; Olsson I; Gullberg U
    Cell Growth Differ; 1995 Jan; 6(1):9-17. PubMed ID: 7718488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells.
    Keren-Tal I; Suh BS; Dantes A; Lindner S; Oren M; Amsterdam A
    Exp Cell Res; 1995 May; 218(1):283-95. PubMed ID: 7737366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of interferon-gamma and retinoic acid or 1 alpha, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937.
    Gullberg U; Nilsson E; Einhorn S; Olsson I
    Exp Hematol; 1985 Aug; 13(7):675-9. PubMed ID: 2411582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-mediated differentiation of the erythroleukemia cell line K562.
    Chylicki K; Ehinger M; Svedberg H; Bergh G; Olsson I; Gullberg U
    Cell Growth Differ; 2000 Jun; 11(6):315-24. PubMed ID: 10910098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of p53 gene in the switch of U937 leukemic cells from growth into differentiation].
    Wu J; Wang ML; Sheng Y; Zhu DX
    Shi Yan Sheng Wu Xue Bao; 1992 Dec; 25(4):311-6. PubMed ID: 1303002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
    Kusumoto M; Ogawa T; Mizumoto K; Ueno H; Niiyama H; Sato N; Nakamura M; Tanaka M
    Clin Cancer Res; 1999 Aug; 5(8):2140-7. PubMed ID: 10473098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
    Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
    Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
    J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells.
    Suzui M; Sunagawa N; Chiba I; Moriwaki H; Yoshimi N
    Int J Oncol; 2006 May; 28(5):1193-9. PubMed ID: 16596235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line.
    Yamasaki F; Hama S; Yoshioka H; Kajiwara Y; Yahara K; Sugiyama K; Heike Y; Arita K; Kurisu K
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):271-83. PubMed ID: 12721754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
    Feldkamp MM; Lau N; Guha A
    Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of heat-shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: relationships with differentiation and apoptosis.
    Garcia-Bermejo L; Vilaboa NE; Perez C; Galan A; De Blas E; Aller P
    Exp Cell Res; 1997 Oct; 236(1):268-74. PubMed ID: 9344607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation and CD11b expression are controlled independently during HL60 cell differentiation initiated by 1,25 alpha-dihydroxyvitamin D(3) or all-trans-retinoic acid.
    Drayson MT; Michell RH; Durham J; Brown G
    Exp Cell Res; 2001 May; 266(1):126-34. PubMed ID: 11339831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.